MET and breast carcinoma: Our findings have elucidated how c-Met mediated inflammatory cytokines affect neutrophil functions during different stages of breast cancer brain metastasis and how LCN2 from N2 neutrophils promote tumor progression, which provides insights into developing potential therapeutic strategies by targeting c-Met signaling and N2 neutrophils.